"Nieminen, Lasse" - Selaus tekijän mukaan TUNICRIS-julkaisut

Viitteet 1-6 / 6

    • Atypical (non-V600E) BRAF mutations in metastatic colorectal cancer in population and real-world cohorts 

      Osterlund, Emerik; Ristimäki, Ari; Mäkinen, Markus J.; Kytölä, Soili; Kononen, Juha; Pfeiffer, Per; Soveri, Leena-Maija; Keinänen, Mauri; Sorbye, Halfdan; Nunes, Luís; Salminen, Tapio; Nieminen, Lasse; Uutela, Aki; Halonen, Päivi; Ålgars, Annika; Sundström, Jari; Kallio, Raija; Ristamäki, Raija; Lamminmäki, Annamarja; Stedt, Hanna; Heervä, Eetu; Kuopio, Teijo; Sjöblom, Tobias; Isoniemi, Helena; Glimelius, Bengt; Österlund, Pia (02 / 2023)
      article
      <p>BRAF-V600E mutation (mt) is a strong negative prognostic and predictive biomarker in metastatic colorectal cancer (mCRC). Non-V600Emt, designated atypical BRAFmt (aBRAFmt) are rare, and little is known about their ...

    • An easily adaptable validated risk score predicts cancer-specific survival in stage II colon cancer 

      Heervä, Eetu; Väliaho, Vesa; Salminen, Tapio; Nieminen, Lasse; Carpelan, Anu; Kurki, Samu; Sundström, Jari; Huhtinen, Heikki; Rantala, Arto; Carpén, Olli; Minn, Heikki; Österlund, Pia; Ålgars, Annika; Ristamäki, Raija (12.10.2020)
      letter

    • Immunohistochemical Glucagon-like Peptide-1 Receptor Expression in Human Insulinomas 

      Vesterinen, Tiina; Peltola, Elina; Leijon, Helena; Hannula, Päivi; Huhtala, Heini; Mäkinen, Markus J.; Nieminen, Lasse; Pirinen, Elina; Rönty, Mikko; Söderström, Mirva; Jaatinen, Pia; Arola, Johanna (10 / 2023)
      article
      <p>Insulinomas are rare functional pancreatic neuroendocrine tumours, which metastasize in 10% of cases. As predicting the prognosis can be challenging, there is a need for the determination of clinicopathological ...

    • Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study) 

      Aho, Sonja; Osterlund, Emerik; Ristimäki, Ari; Nieminen, Lasse; Sundström, Jari; Mäkinen, Markus J.; Kuopio, Teijo; Kytölä, Soili; Ålgars, Annika; Ristamäki, Raija; Heervä, Eetu; Kallio, Raija; Halonen, Päivi; Soveri, Leena Maija; Nordin, Arno; Uutela, Aki; Salminen, Tapio; Stedt, Hanna; Lamminmäki, Annamarja; Muhonen, Timo; Kononen, Juha; Glimelius, Bengt; Isoniemi, Helena; Lehto, Juho T.; Lehtomäki, Kaisa; Osterlund, Pia (03 / 2024)
      article
      <p>The primary tumor location (PTL) is associated with the phenotype, metastatic sites, mutations, and outcomes of metastatic colorectal cancer (mCRC) patients, but this has mostly been studied according to sidedness ...

    • Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study 

      -, -; Uutela, Aki; Nordin, Arno; Osterlund, Emerik; Halonen, Päivi; Kallio, Raija; Soveri, Leena-Maija; Salminen, Tapio; Ålgars, Annika; Ristimäki, Ari; Ovissi, Ali; Lamminmäki, Annamarja; Muhonen, Timo; Kononen, Juha; Ristamäki, Raija; Heervä, Eetu; Stedt, Hanna; Lehtomäki, Kaisa; Kytölä, Soili; Sundström, Jari; Mäkinen, Markus J; Nieminen, Lasse; Kuopio, Teijo; Keinänen, Mauri; Osterlund, Pia; Isoniemi, Helena (2022)
      article

    • Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study 

      Uutela, Aki; Osterlund, Emerik; Halonen, Päivi; Kallio, Raija; Ålgars, Annika; Salminen, Tapio; Lamminmäki, Annamarja; Soveri, Leena Maija; Ristamäki, Raija; Lehtomäki, Kaisa; Stedt, Hanna; Heervä, Eetu; Muhonen, Timo; Kononen, Juha; Nordin, Arno; Ovissi, Ali; Kytölä, Soili; Keinänen, Mauri; Sundström, Jari; Nieminen, Lasse; Mäkinen, Markus J.; Kuopio, Teijo; Ristimäki, Ari; Isoniemi, Helena; Osterlund, Pia (2022)
      article
      <p>Background: Outcomes after metastasectomy for metastatic colorectal cancer (mCRC) vary with RAS and BRAF mutational status, but their effects on resectability and conversion rates have not been extensively studied. ...